Physiology and pathophysiology of growth hormone-binding protein: Methodological and clinical aspects

Growth Hormone and IGF Research

Volumn 16, Issue 1, 2006, Pages 1-28

  Fisker, Sanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Assay; Binding protein; Body composition; Growth hormone; Receptor

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SEX HORMONE;

BINDING AFFINITY; BODY COMPOSITION; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BINDING; HORMONE DETERMINATION; HUMAN; IN VIVO STUDY; METHODOLOGY; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW;

ANIMALS; CARRIER PROTEINS; HUMANS; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; RECEPTORS, SOMATOTROPIN;

EID: 32144437409     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2005.11.001     Document Type: Review

References (316)

1. B.C. Cunningham M. Ultsch A.M. de Vos M.G. Mulkerrin K.R. Clauser J.A. Wells Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule Science 254 1991 821-825
2. A.M. de Vos M. Ultsch A.A. Kossiakoff Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex Science 255 1992 306-312
3. S.J. Frank Growth hormone signalling and its regulation: Preventing too much of a good thing Growth Horm. IGF Res. 11 2001 201-212
4. T. Zhu E.L. Goh R. Graichen L. Ling P.E. Lobie Signal transduction via the growth hormone receptor Cell Signal. 13 2001 599-616
5. R.J. Ross K.C. Leung M. Maamra W. Bennett N. Doyle M.J. Waters K.K. Ho Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant) reveal effects of pegylation and evidence that it binds to a receptor dimer J. Clin. Endocrinol. Metab. 86 2001 1716-1723
6. J. Gent P. Van Kerkhof M. Roza G. Bu G.J. Strous Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis Proc. Natl. Acad. Sci. USA 99 2002 9858-9863
7. C.J. Greenhalgh W.S. Alexander Suppressors of cytokine signalling and regulation of growth hormone action Growth Horm. IGF Res. 14 2004 200-206
8. P.J. Godowski et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism Proc. Natl. Acad. Sci. USA 86 1989 8083-8087
9. R.J. Ross N. Esposito X.Y. Shen S. Von-Laue S.L. Chew P.R. Dobson V.M. Postel J. Finidori A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein Mol. Endocrinol. 11 1997 265-273
10. F. Dastot M.L. Sobrier P. Duquesnoy B. Duriez M. Goossens S. Amselem Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein Proc. Natl. Acad. Sci. USA 93 1996 10723-10728
11. T. Amit T. Bergman F. Dastot M.B. Youdim S. Amselem Z. Hochberg A membrane-fixed, truncated isoform of the human growth hormone receptor J. Clin. Endocrinol. Metab. 82 1997 3813-3817
12. M. Maamra J. Finidori S. Von Laue S. Simon S. Justice J. Webster S. Dower R. Ross Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform is very rapidly internalized independent of Jak2-Stat5 signaling J. Biol. Chem. 274 1999 14791-14798
13. K. Iida Y. Takahashi H. Kaji M.O. Takahashi Y. Okimura O. Nose H. Abe K. Chihara Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein J. Clin. Endocrinol. Metab. 84 1999 1011-1016
14. M. Ballesteros K.C. Leung R.J. Ross T.P. Iismaa K.K. Ho Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues J. Clin. Endocrinol. Metab. 85 2000 2865-2871
15. F. Dastot P. Duquesnoy M.L. Sobrier M. Goossens S. Amselem Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein Mol. Cell. Endocrinol. 137 1998 79-84
16. K. Iida Y. Takahashi H. Kaji S. Yoshioka M. Murata G. Iguchi Y. Okimura K. Chihara Diverse regulation of full-length and truncated growth hormone receptor expression in 3T3-L1 adipocytes Mol. Cell. Endocrinol 210 2003 21-29
17. M. Urbanek J.N. MacLeod N.E. Cooke S.A. Liebhaber Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript Mol. Endocrinol. 6 1992 279-287
18. J. Pantel K. Machinis M.L. Sobrier P. Duquesnoy M. Goossens S. Amselem Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution J. Biol. Chem. 275 2000 18664-18669
19. B. Seidel A. Glasow M. Schutt W. Kiess Z. Wu C.J. Strasburger J. Kratzsch Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum Eur. J. Endocrinol. 148 2003 317-324
20. J. Pantel J. Grulich-Henn M. Bettendorf C.J. Strasburger U. Heinrich S. Amselem Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd 3 isoform J. Clin. Endocrinol. Metab. 88 2003 1705-1710
21. G. Zogopoulos R. Figueiredo A. Jenab Z. Ali Y. Lefebvre C.G. Goodyer Expression of exon 3-retaining and -deleted human growth hormone receptor messenger ribonucleic acid isoforms during development J. Clin. Endocrinol. Metab. 81 1996 775-782
22. M.L. Stallings-Mann R.L. Ludwiczak K.W. Klinger F. Rottman Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism Proc. Natl. Acad. Sci. USA 93 1996 12394-12399
23. N. Esposito P. Paterlini P.A. Kelly M.C. Postel-Vinay J. Finidori Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma Mol. Cell. Endocrinol. 103 1994 13-20
24. M. Mercado N. Davila J.F. McLeod G. Baumann Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues J. Clin. Endocrinol. Metab. 78 1994 731-735
25. R.B. Wickelgren K.L. Landin C. Ohlsson L.M. Carlsson Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner J. Clin. Endocrinol. Metab. 80 1995 2154-2157
26. C. Decouvelaere J.P. Peyrat J. Bonneterre J. Djiane H. Jammes Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer Cell Growth Differ. 6 1995 477-483
27. M. Urbanek J.E. Russell N.E. Cooke S.A. Liebhaber Functional characterization of the alternatively spliced, placental human growth hormone receptor J. Biol. Chem. 268 1993 19025-19032
28. J. Kratzsch Z. Wu W. Kiess B. Dehmel A. Bosse-Henck W. Reuter C.D. Pflaum C.J. Strasburger The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently Clin. Endocrinol. (Oxf.) 54 2001 61-68
29. S.C. Dos L. Essioux C. Teinturier M. Tauber V. Goffin P. Bougneres A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone Nat. Genet. 36 2004 720-724
30. M.L. Sobrier P. Duquesnoy B. Duriez S. Amselem M. Goossens Expression and binding properties of two isoforms of the human growth hormone receptor FEBS Lett. 319 1993 16-20
31. G. Baumann M.W. Stolar K. Amburn C.P. Barsano B.C. DeVries A specific growth hormone-binding protein in human plasma: Initial characterization J. Clin. Endocrinol. Metab. 62 1986 134-141
32. A.C. Herington S. Ymer J. Stevenson Identification and characterization of specific binding proteins for growth hormone in normal human sera J. Clin. Invest. 77 1986 1817-1823
33. D.W. Leung S.A. Spencer G. Cachianes R.G. Hammonds C. Collins W.J. Henzel R. Barnard M.J. Waters W.I. Wood Growth hormone receptor and serum binding protein: Purification, cloning and expression Nature 330 1987 537-543
34. S.A. Spencer R.G. Hammonds W.J. Henzel H. Rodriguez M.J. Waters W.I. Wood Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence J. Biol. Chem. 263 1988 7862-7867
35. Y. Zhang J. Jiang R.A. Black G. Baumann S.J. Frank Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation Endocrinology 141 2000 4342-4348
36. J.A. Schantl M. Roza P. Van Kerkhof G.J. Strous The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha converting enzyme (TACE) Biochem. JPt. 2003
37. R. Guan Y. Zhang J. Jiang C.A. Baumann R.A. Black G. Baumann S.J. Frank Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: Relationship to GH receptor downregulation Endocrinology 142 2001 1137-1147
38. Y. Zhang R. Guan J. Jiang J.J. Kopchick R.A. Black G. Baumann S.J. Frank Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis J. Biol. Chem. 276 2001 24565-24573
39. M. Mercado G. Baumann A growth hormone/prolactin-binding protein in human milk J. Clin. Endocrinol. Metab. 79 1994 1637-1641
40. G. Baumann M.A. Shaw A second, lower affinity growth hormone-binding protein in human plasma J. Clin. Endocrinol. Metab. 70 1990 680-686
41. A. Tar J.F. Hocquette J.C. Souberbielle J.P. Clot R. Brauner M.C. Postel Vinay Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration J. Clin. Endocrinol. Metab. 71 1990 1202-1207
42. J. Kratzsch T. Selisko G. Birkenmeier Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood J. Clin. Endocrinol. Metab. 80 1995 585-590
43. G. Baumann M.A. Shaw K. Amburn Regulation of plasma growth hormone-binding proteins in health and disease Metabolism 38 1989 683-689
44. C.P. Barsano G. Baumann Simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone? Endocrinology 124 1989 1101-1106
45. G. Baumann M.L. Vance M.A. Shaw M.O. Thorner Plasma transport of human growth hormone in vivo J. Clin. Endocrinol. Metab. 71 1990 470-473
46. W. Borth Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics FASEB J. 6 1992 3345-3353
47. T. Amit Z. Hochberg M.J. Waters R.J. Barkey Growth hormone- and prolactin-binding proteins in mammalian serum Endocrinology 131 1992 1793-1803
48. W.C. Smith J. Kuniyoshi F. Talamantes Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains Mol. Endocrinol. 3 1989 984-990
49. W.R. Baumbach D.L. Horner J.S. Logan The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor Genes Dev. 3 1989 1199-1205
50. H. Sadeghi B.S. Wang A.L. Lumanglas J.S. Logan W.R. Baumbach Identification of the origin of the growth hormone-binding protein in rat serum Mol. Endocrinol. 4 1990 1799-1805
51. A. Edens J.N. Southard F. Talamantes Mouse growth hormone-binding protein and growth hormone receptor transcripts are produced from a single gene by alternative splicing Endocrinology 135 1994 2802-2805
52. B. Carlsson H. Billig L. Rymo O.G. Isaksson Expression of the growth hormone-binding protein messenger RNA in the liver and extrahepatic tissues in the rat: Co-expression with the growth hormone receptor Mol. Cell. Endocrinol. 173 1990 R1-R6
53. A. Sotiropoulos L. Goujon G. Simonin P.A. Kelly M.C. Postel Vinay J. Finidori Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor Endocrinology 132 1993 1863-1865
54. S.M. Harrison R. Barnard K.Y. Ho I. Rajkovic M.J. Waters Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor Endocrinology 136 1995 651-659
55. J.F. Martini A. Pezet C.Y. Guezennec M. Edery M.C. Postel-Vinay P.A. Kelly Monkey growth hormone (GH) receptor gene expression. Evidence for two mechanisms for the generation of the GH binding protein J. Biol. Chem. 272 1997 18951-18958
56. M.T. Sorensen S. Chaudhuri I. Louveau M.E. Coleman T.D. Etherton Growth hormone binding proteins in pig adipose tissue: Number, size and effects of pGH treatment on pGH and bGH binding Domest. Anim. Endocrinol. 9 1992 13-24
57. V. Goffin P.A. Kelly Prolactin and growth hormone receptors Clin. Endocrinol. (Oxf.) 45 1996 247-255
58. H.B. Lowman B.C. Cunningham J.A. Wells Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen J. Biol. Chem. 266 1991 10982-10988
59. G. Baumann Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins Endocr. Rev. 12 1991 424-449
60. S.I. Ymer J.L. Stevenson A.C. Herington Identification of a rabbit liver cytosolic binding protein for human growth hormone Biochem. J. 221 1984 617-622
61. A.C. Herington A.I. Smith C. Wallace J.L. Stevenson Partial purification from human serum of a specific binding protein for human growth hormone Mol. Cell. Endocrinol. 53 1987 203-209
62. G. Baumann K. Amburn M.A. Shaw The circulating growth hormone (GH)-binding protein complex: A major constituent of plasma GH in man Endocrinology 122 1988 976-984
63. J.D. Veldhuis M.L. Johnson L.M. Faunt M. Mercado G. Baumann Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications J. Clin. Invest. 91 1993 629-641
64. G. Baumann N. Davila M.A. Shaw J. Ray S.A. Liebhaber N.E. Cooke Binding of human growth hormone (GH)-variant (placental GH) to GH-binding proteins in human plasma J. Clin. Endocrinol. Metab. 73 1991 1175-1179
65. S.C. Souza G.P. Frick X. Wang J.J. Kopchick R.B. Lobo H.M. Goodman A single arginine residue determines species specificity of the human growth hormone receptor Proc. Natl. Acad. Sci. USA 92 1995 959-963
66. N. Hattori A. Shimatsu Y. Kato H. Imura Growth hormone and growth hormone binding protein in human urine Kidney Int. 37 1990 951-954
67. H. Maheshwari S. Lillioja C.E. Castillo M. Mercado G. Baumann Growth hormone-binding protein in human lymph J. Clin. Endocrinol. Metab. 80 1995 3582-3584
68. K.M. Fairhall D.F. Carmignac I.C. Robinson Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig Endocrinology 131 1992 1963-1969
69. T. Amit K. Hartmann G. Shoshany Y. Baruch M.B. Youdim Z. Hochberg The turnover of growth hormone (GH)-binding protein and GH receptor in rabbit and rat Mol. Cell. Endocrinol. 94 1993 149-154
70. G. Baumann K.D. Amburn T.A. Buchanan The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone J. Clin. Endocrinol. Metab. 64 1987 657-660
71. G. Baumann M.A. Shaw T.A. Buchanan In vivo kinetics of a covalent growth hormone-binding protein complex Metabolism 38 1989 330-333
72. G. Massa Growth hormone-binding proteins during human pregnancy: maternal, fetal and neonatal data Proc. Soc. Exp. Biol. Med. 206 1994 316-319
73. R.W. Holl R. Snehotta B. Siegler W. Scherbaum E. Heinze Binding protein for human growth hormone: Effects of age and weight Horm. Res. 35 1991 190-197
74. A.C. Herington S.I. Ymer J.L. Stevenson Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum Biochem. Biophys. Res. Commun. 139 1986 150-155
75. J.F. Hocquette M.C. Postel Vinay J. Djiane A. Tar P.A. Kelly Human liver growth hormone receptor and plasma binding protein: Characterization and partial purification Endocrinology 127 1990 1665-1672
76. G. Baumann H.B. Lowman M. Mercado J.A. Wells The stoichiometry of growth hormone-binding protein complexes in human plasma: Comparison with cell surface receptors J. Clin. Endocrinol. Metab. 78 1994 1113-1118
77. T.K. Hansen S. Fisker B. Hansen H.H. Sorensen J.S. Christiansen J.O. Jorgensen H. Orskov Impact of GHBP interference on estimates of GH and GH pharmacokinetics Clin. Endocrinol. (Oxf.) 57 2002 779-786
78. M. Tzanela C. Wagner G.S. Tannenbaum Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats Endocrinology 138 1997 5316-5324
79. D. Turyn F.P. Dominici A.I. Sotelo A. Bartke Growth hormone-binding protein enhances growth hormone activity in vivo Am. J. Physiol. 273 1997 E549-E556
80. D. Haffner F. Schaefer J. Girard E. Ritz O. Mehls Metabolic clearance of recombinant human growth hormone in health and chronic renal failure J. Clin. Invest. 93 1994 1163-1171
81. L. Lim S.A. Spencer P. McKay M.J. Waters Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein Endocrinology 127 1990 1287-1291
82. D.A. Mannor L.M. Winer M.A. Shaw G. Baumann Plasma growth hormone (GH)-binding proteins: Effect on GH binding to receptors and GH action J. Clin. Endocrinol. Metab. 73 1991 30-34
83. B.S. Hansen S. Hjorth B.S. Welinder L. Skriver P. De Meyts The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the downregulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells Endocrinology 133 1993 2809-2817
84. Z. Hochberg T. Bick T. Amit Stoichiometry of the pulsating growth hormone (GH) binding to the GH-binding protein and the turnover GH-receptor Proc. Soc. Exp. Biol. Med. 206 1994 249-253
85. M. Wada H. Uchida M. Ikeda B. Tsunekawa N. Naito S. Banba E. Tanaka Y. Hashimoto M. Honjo The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma Mol. Endocrinol. 12 1998 146-156
86. N. Asada Y. Takahashi M. Honjo Effects of 22K or 20K human growth hormone on lipolysis, leptin production in adipocytes in the presence and absence of human growth hormone binding protein Horm. Res. 54 2000 203-207
87. P.E. Mullis A. Eble J.K. Wagner R.W. Holl A. Silbergeld Z. Laron Effect of different serum concentrations of growth hormone binding protein (GHBP) on the regulation of GH receptor/GHBP gene transcription in a human hepatoma cell line Horm. Res. 47 1997 73-80
88. R.G. Clark D.L. Mortensen L.M. Carlsson S.A. Spencer P. McKay M. Mulkerrin J. Moore B.C. Cunningham Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat Endocrinology 137 1996 4308-4315
89. G. Scatchard Ann. NY Acad. Sci. 51 1949 660-672
90. G. Baumann M.A. Shaw K. Amburn A rapid and simple assay for growth hormone-binding protein activity in human plasma Acta Endocrinol. Copenh. 119 1988 529-534
91. T. Amit R.J. Barkey M.B. Youdim Z. Hochberg A new and convenient assay of growth hormone-binding protein activity in human serum J. Clin. Endocrinol. Metab. 71 1990 474-480
92. K.K. Ho J.O. Jorgensen E. Valiontis M.J. Waters I.A. Rajkovic J.S. Christiansen Different modes of growth hormone (GH) administration do not change GH binding protein activity in man Clin. Endocrinol. Oxf. 38 1993 143-148
93. K.K. Ho E. Valiontis M.J. Waters I.A. Rajkovic Regulation of growth hormone binding protein in man: Comparison of gel chromatography and immunoprecipitation methods J. Clin. Endocrinol. Metab. 76 1993 302-308
94. L. Ebdrup S. Fisker H.H. Sorensen M.B. Ranke H. Orskov Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein Horm. Res. 51 Suppl. 1 1999 20-26
95. J. Kratzsch W.F. Blum M. Ventz T. Selisko G. Birkenmeyer E. Keller Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration Eur. J. Endocrinol. 132 1995 306-312
96. L.M. Carlsson A.M. Rowland R.G. Clark N. Gesundheit W.L. Wong Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood J. Clin. Endocrinol. Metab. 73 1991 1216-1223
97. I.A. Rajkovic E. Valiontis K.K. Ho Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods J. Clin. Endocrinol. Metab. 78 1994 772-777
98. S. Fisker J. Frystyk L. Skriver E. Vestbo K.K.Y. Ho H. Ørskov A simple rapid immunometric assay for determination of functional and growth hormone (GH)-occupied GH-binding protein in human serum Eur. J. Clin. Invest. 26 1996 779-785
99. L. Carlsson M. Mercado G. Baumann M. Stene K. Attie M. Reichert K. Albertsson Wikland K. Dawson W.L. Wong Assay systems for the growth hormone-binding protein Proc. Soc. Exp. Biol. Med. 206 1994 312-315
100. M. Mercado L. Carlsson R. Vitangcol G. Baumann Growth hormone-binding protein determination in plasma: A comparison of immunofunctional and growth hormone-binding assays J. Clin. Endocrinol. Metab. 76 1993 1291-1294
101. G. Fuh M.G. Mulkerrin S. Bass N. McFarland M. Brochier J.H. Bourell D.R. Light J.A. Wells The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain J. Biol. Chem. 265 1990 3111-3115
102. T. Jan M.A. Shaw G. Baumann Effects of growth hormone-binding proteins on serum growth hormone measurements J. Clin. Endocrinol. Metab. 72 1991 387-391
103. I.M. Chapman M.L. Hartman M. Straume M.L. Johnson J.D. Veldhuis M.O. Thorner Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women J. Clin. Endocrinol. Metab. 78 1994 1312-1319
104. C. Jansson C. Boguszewski S. Rosberg L. Carlsson K. Albertsson-Wikland Growth-hormone (GH) assays: Influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein Clin. Chem. 43 1997 950-956
105. S. Fisker L. Ebdrup H. Ørskov Influence of growth hormone binding protein on growth hormone estimation in different immunoassays Scand. J. Clin. Lab. Invest. 58 1998 373-381
106. C.J. Strasburger Z. Wu C.D. Pflaum R.A. Dressendorfer Immunofunctional assay of human growth hormone (hGH) in serum: A possible consensus for quantitative hGH measurement J. Clin. Endocrinol. Metab. 81 1996 2613-2620
107. M.T. Dattani P.C. Hindmarsh C.G. Brook I.C. Robinson N.J. Marshall Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system J. Endocrinol. 140 1994 445-453
108. Consensus statement: Benefits versus risks of medical therapy for acromegaly. Acromegaly Therapy Consensus Development Panel, Am. J. Med. 97 (1994) 468-473.
109. P.S.N.S.W.A.Participants in the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency, Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metab. 83 (1998) 379-381.
110. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society. GH Research Society, J. Clin. Endocrinol. Metab. 85 (2000) 3990-3993.
111. R. Vasilatos Younken B.J. Andersen R.W. Rosebrough J.P. McMurtry W.L. Bacon Identification of circulating growth hormone-binding proteins in domestic poultry: An initial characterization J. Endocrinol. 130 1991 115-122
112. S.L. Davis M. Graf C.A. Morrison T.R. Hall P.J. Swift Identification and partial purification of serum growth hormone binding protein in domestic animal species J. Anim. Sci. 70 1992 773-780
113. B. Bingham E.R. Oldham W.R. Baumbach Regulation of growth hormone receptor and binding protein expression in domestic species Proc. Soc. Exp. Biol. Med. 206 1994 195-199
114. S.L. Davis N.B. Wehr D.M. Laird A.C. Hammond Serum growth hormone-binding protein (GHBP) in domestic animals as measured by ELISA J. Anim. Sci. 72 1994 1719-1727
115. K.L. Hull A. Thiagarajah S. Harvey Cellular localization of growth hormone receptors/binding proteins in immune tissues Cell Tissue Res. 286 1996 69-80
116. H. Kaji S. Ohashi H. Abe K. Chihara Regulation of the growth hormone (GH) receptor and GH-binding protein mRNA Proc. Soc. Exp. Biol. Med. 206 1994 257-262
117. A.A. Butler B. Funk B.H. Breier D. LeRoith C.T. Roberts Jr. P.D. Gluckman Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat Mol. Cell. Endocrinol. 116 1996 181-189
118. T. Amit R.J. Barkey T. Bick P. Hertz M.B. Youdim Z. Hockberg Identification of growth hormone binding protein in rat serum Mol. Cell. Endocrinol. 70 1990 197-202
119. T.S. Tiong A.C. Herington Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat Endocrinology 129 1991 1628-1634
120. S.D. Cramer L. Wong R.S. Kensinger L. Ogren F. Talamantes Regulation of the hepatic growth hormone receptor and serum growth hormone-binding protein during pregnancy in the mouse: Effects of litter size Endocrinology 131 1992 2914-2920
121. S.D. Cramer R. Barnard C. Engbers L. Ogren F. Talamantes Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse Endocrinology 131 1992 876-882
122. F. Talamantes R. Ortiz Structure and regulation of expression of the mouse GH receptor J. Endocrinol. 175 2002 55-59
123. T. Bick Z. Hochberg T. Amit O.G. Isaksson J.O. Jansson Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I Endocrinology 131 1992 423-429
124. D. Maiter J.L. Walker E. Adam B. Moatsstaats N. Mulumba J.M. Ketelslegers L.E. Underwood Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver Endocrinology 130 1992 3257-3264
125. D.F. Carmignac I.C. Robinson B. Enberg G. Norstedt Growth hormone receptor regulation in growth hormone-deficient dwarf rats J. Endocrinol. 138 1993 267-274
126. E.F. Gevers J.M. Wit I.C. Robinson Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat Endocrinology 137 1996 1013-1018
127. T. Laursen J.O.L. Jørgensen K.K.Y. Ho J. Møller J.S. Christiansen Serum concentrations of growth hormone GH binding protein in GH-deficient patients: Impact of mode of GH administration Endocrinol. Metab. 4 1997 281-287
128. G. Massa N. Mulumba J.M. Ketelslegers M. Maes Initial characterization and sexual dimorphism of serum growth hormone-binding protein in adult rats Endocrinology 126 1990 1976-1980
129. D.F. Carmignac T. Wells L.M. Carlsson R.G. Clark I.C. Robinson Growth hormone (GH)-binding protein in normal and GH-deficient dwarf rats J. Endocrinol. 135 1992 447-457
130. R. Barnard J. Mulcahy J. Garcia Aragon B. Wyse P.C. Owens S.W. Rowlinson F. Talamantes W.R. Baumbach M.J. Waters Serum growth hormone binding protein and hepatic GH binding sites in the Lewis dwarf rat: Effects of IGF-I and GH Growth Regul. 4 1994 147-154
131. D.F. Carmignac B.G. Gabrielsson I.C. Robinson Growth hormone binding protein in the rat: Effects of gonadal steroids Endocrinology 133 1993 2445-2452
132. Y.M. Yu H.M. Domene J. Sztein D.R. Counts F. Cassorla Developmental changes and differential regulation by testosterone and estradiol of growth hormone receptor expression in the rabbit Eur. J. Endocrinol. 135 1996 583-590
133. A. Silbergeld L. Lazar B. Erster R. Keret R. Tepper Z. Laron Serum growth hormone binding protein activity in healthy neonates, children and young adults: Correlation with age, height and weight Clin. Endocrinol. Oxf. 31 1989 295-303
134. T.J. Merimee B. Russell S. Quinn W. Riley Hormone and receptor studies: relationship to linear growth in childhood and puberty J. Clin. Endocrinol. Metab. 73 1991 1031-1037
135. T.J. Merimee B. Russell S. Quinn Growth hormone-binding proteins of human serum: Developmental patterns in normal man J. Clin. Endocrinol. Metab. 75 1992 852-854
136. Z. Zadik Z. Amnon Y. Altman M. Chen The effect of exogenous and endogenous growth hormone on plasma growth hormone binding activity in prepubertal children Horm. Res. 40 1993 161-167
137. M. Phillip S.A. Chalew R.J.J. McCarter T. Amit A.A. Kowarski Z. Hochberg The relationship of growth rate, plasma growth hormone (GH) concentration, and GH-binding protein Metabolism 45 1996 424-429
138. L. Gelander R. Bjarnason L.M. Carlsson K. Albertsson-Wikland Growth hormone-binding protein levels over one year in healthy prepubertal children: Intraindividual variation and correlation with height velocity Pediatr. Res. 43 1998 256-261
139. P.M.J. Martha E.O. Reiter N. Davila M.A. Shaw J.H. Holcombe G. Baumann Serum growth hormone (GH)-binding protein/receptor: An important determinant of GH responsiveness J. Clin. Endocrinol. Metab. 75 1992 1464-1469
140. N. Hattori H. Kurahachi K. Ikekubo T. Ishihara K. Moridera M. Hino Y. Saiki H. Imura Effects of sex and age on serum GH binding protein levels in normal adults Clin. Endocrinol. Oxf. 35 1991 295-297
141. M. Fontoura J.F. Hocquette J.P. Clot A. Tar R. Brauner R. Rappaport M.C. Postel Vinay Regulation of the growth hormone binding proteins in human plasma Acta Endocrinol. Copenh. 124 Suppl. 2 1991 10-13
142. M. Bondanelli A. Margutti M.R. Ambrosio L. Plaino L. Cobellis F. Petraglia E.C. degli Uberti Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: Roles of body weight and estrogen levels J. Clin. Endocrinol. Metab. 86 2001 1973-1980
143. H. Maheshwari L. Sharma G. Baumann Decline of plasma growth hormone binding protein in old age J. Clin. Endocrinol. Metab. 81 1996 995-997
144. B. Bulow B. Ahren S. Fisker O. Dehlin B. Hagberg E. Jensen T. Svensson G. Samuelsson E.M. Erfurth The gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormones Clin. Endocrinol. (Oxf.) 59 2003 482-486
145. K.J. Snow M.A. Shaw L.M. Winer G. Baumann Diurnal pattern of plasma growth hormone-binding protein in man J. Clin. Endocrinol. Metab. 70 1990 417-420
146. P.J. Ho N. Gesundheit W.L. Wong S.H. Huang R.D. Friberg A.L. Barkan Dynamic changes of growth hormone-binding protein concentrations in normal men and patients with acromegaly: Effects of short-term fasting Metabolism 44 1995 667-672
147. L.M. Carlsson S. Rosberg R.V. Vitangcol W.L. Wong K. Albertsson Wikland Analysis of 24-hour plasma profiles of growth hormone (GH)-binding protein, GH/GH-binding protein-complex, and GH in healthy children J. Clin. Endocrinol. Metab. 77 1993 356-361
148. R. Bjarnason K. Albertsson Wikland L.M. Carlsson Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children J. Clin. Endocrinol. Metab. 80 1995 2756-2760
149. Z. Hochberg T. Amit Z. Zadik Twenty-four-hour profile of plasma growth hormone-binding protein J. Clin. Endocrinol. Metab. 72 1991 236-239
150. A. Juul S. Fisker T. Scheike T. Hertel J. Muller H. Orskov N.E. Skakkebaek Serum levels of growth hormone binding protein in children with normal and precocious puberty: Relation to age, gender, body composition and gonadal steroids Clin. Endocrinol. (Oxf.) 52 2000 165-172
151. S. Fisker J.O.L. Jørgensen N. Vahl H. Ørskov J.S. Christiansen Impact of gender and androgen status on insulin-like-growth-factor-I levels in normal and growth hormone deficient adults Eur. J. Endocrinol. 141 1999 601-608
152. G. Massa A. Igout L. Rombauts F. Frankenne M. Vanderschueren Lodeweyckx Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women Clin. Endocrinol. Oxf. 39 1993 569-575
153. A.J. Weissberger K.K. Ho L. Lazarus Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women J. Clin. Endocrinol. Metab. 72 1991 374-381
154. N. Jospe C.C. Orlowski R.W. Furlanetto Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome J. Pediatr. Endocrinol. Metab. 8 1995 111-116
155. J.J. Kelly I.A. Rajkovic A.J. O'Sullivan C. Sernia K.K. Ho Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women Clin. Endocrinol. Oxf. 39 1993 561-567
156. C.G. Gravholt R.W. Naeraa S. Fisker J.S. Christiansen Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17b-estradiol J. Clin. Endocrinol. Metab. 82 1997 2570-2577
157. T.P. Ip D.M. Hoffman A.J. O'Sullivan K.C. Leung K.K. Ho Do androgens regulate growth hormone-binding protein in adult man? J. Clin. Endocrinol. Metab. 80 1995 1278-1282
158. M.C. Postel Vinay A. Tar J.F. Hocquette J.P. Clot M. Fontoura R. Brauner R. Rappaport Human plasma growth hormone (GH)-binding proteins are regulated by GH and testosterone J. Clin. Endocrinol. Metab. 73 1991 197-202
159. B.S. Keenan G.E. Richards M. Mercado J.S. Dallas G.D. Eakman G. Baumann Androgen regulation of growth hormone binding protein Metabolism 45 1996 1521-1526
160. S. Fisker H. Norrelund A. Juul N.E. Skakkebaek J.S. Christiansen J.O. Jorgensen The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males Growth Horm. IGF Res. 11 2001 104-109
161. S. Fisker N. Vahl J.O.L. Jørgensen J.S. Christiansen H. Ørskov H. Abdominal Abdominal fat determines growth hormone binding protein levels in healthy non-obese adults. J. Clin. Endocrinol. Metab. 1997 82 123-128.
162. S. Fisker N. Vahl T.B. Hansen J.O.L. Jørgensen C. Hagen H. Ørskov J.S. Christiansen Growth hormone (GH) substitution for one year normalises elevated Gh-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial Growth Horm. IGF Res. 8 1998 105-112
163. Z. Hochberg P. Hertz V. Colin S. Ish Shalom D. Yeshurun M.B. Youdim T. Amit The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa Metabolism 41 1992 106-112
164. N.H. Golden P. Kreitzer M.S. Jacobson F.I. Chasalow J. Schebendach S.M. Freedman I.R. Shenker Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa J. Pediatr. 125 1994 655-660
165. J.O. Jorgensen S.B. Pedersen J. Borglum J. Frystyk K.K. Ho J.S. Christiansen H. Orskov W.F. Blum B. Richelsen Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: A double-blind, placebo-controlled study Eur. J. Endocrinol. 133 1995 65-70
166. M.C. Postel Vinay C. Saab M. Gourmelen Nutritional status and growth hormone-binding protein Horm. Res. 44 1995 177-181
167. M.H. Rasmussen K.K. Ho L. Kjems J. Hilsted Serum growth hormone-binding protein in obesity: Effect of a short-term, very low calorie diet and diet-induced weight loss J. Clin. Endocrinol. Metab. 81 1996 1519-1524
168. R.K. Stoving A. Flyvbjerg J. Frystyk S. Fisker J. Hangaard M. Hansen-Nord C. Hagen Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis J. Clin. Endocrinol. Metab. 84 1999 1346-1350
169. M. Luthman S. Stock S. Werner K. Bremme Growth hormone-binding protein in plasma is inversely correlated to placental lactogen and augmented with increasing body mass index in healthy pregnant women and women with gestational diabetes mellitus Gynecol. Obstet. Invest. 38 1994 145-150
170. R. Barnard F.Y. Chan H.D. McIntyre Growth hormone-binding protein in normal and pathologic gestation: Correlations with maternal diabetes and fetal growth J. Clin. Endocrinol. Metab. 82 1997 1879-1884
171. P.M.J. Martha A.D. Rogol R.M. Blizzard M.A. Shaw G. Baumann Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys J. Clin. Endocrinol. Metab. 73 1991 175-181
172. Z. Blumenfeld R.J. Barkey M.B. Youdim J.M. Brandes T. Amit Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction with menopausal gonadotropins, GH, and gestation J. Clin. Endocrinol. Metab. 75 1992 1242-1249
173. P.M.J. Martha A.D. Rogol L.M. Carlsson N. Gesundheit R.M. Blizzard A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum growth hormone-binding protein J. Clin. Endocrinol. Metab. 77 1993 452-457
174. G. Massa L. Dooms R. Bouillon M. Vanderschueren Lodeweyckx Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus Diabetologia 36 1993 239-243
175. C.A. Roelen H.P. Koppeschaar W.R. de Vries Y.E. Snel M.E. Doerga P.M. Zelissen J.H. Thijssen M.A. Blankenstein Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein J. Clin. Endocrinol. Metab. 82 1997 760-764
176. S. Moller S. Fisker U. Becker J.H. Henriksen A comparison of circulating and regional growth hormone-binding protein in cirrhosis Metabolism 50 2001 1340-1345
177. S. Fisker N. Vahl T.B. Hansen J.O.L. Jørgensen C. Hagen H. Ørskov J.S. Christiansen Serum leptin is increased in growth hormone deficient adults: Relationship to body composition and effects of placebo-controlled growth hormone therapy for one year Metabolism 46 1997 812-817
178. J. Kratzsch B. Dehmel F. Pulzer E. Keller P. Englaro W.F. Blum M. Wabitsch Increased serum GHBP levels in obese pubertal children and adolescents: Relationship to body composition, leptin and indicators of metabolic disturbances Int. J. Obes. Relat. Metab. Disord. 21 1997 1130-1136
179. R. Bjarnason M. Boguszewski J. Dahlgren L. Gelander B. Kristrom S. Rosberg B. Carlsson K. Albertsson-Wikland L.M. Carlsson Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children Eur. J. Endocrinol. 137 1997 68-73
180. M.A. Llopis et al. Growth hormone-binding protein directly depends on serum leptin levels in adults with different nutritional status J. Clin. Endocrinol. Metab. 83 1998 2006-2011
181. C.M. Florkowski R. Barnard J.H. Livesey T. Veveris E.A. Espiner R.A. Donald Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response Growth Horm. IGF Res. 9 1999 35-40
182. J.M. Fernandez-Real M.L. Granada A. Ruzafa R. Casamitjana W. Ricart Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin Clin. Endocrinol. (Oxf.) 52 2000 159-164
183. S. Bluher C.S. Mantzoros The role of leptin in regulating neuroendocrine function in humans J. Nutr. 134 2004 2469S-2474S
184. M. Maffei et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat. Med. 1 1995 1155-1161
185. S.M. Haffner M.P. Stern H. Miettinen M. Wei R.L. Gingerich Leptin concentrations in diabetic and nondiabetic Mexican-Americans Diabetes 45 1996 822-824
186. H. Masuzaki et al. Human obese gene expression: Adipocyte-specific expression and regional differences in the adipose tissue Diabetes 44 1995 855-858
187. A. Dua M.I. Hennes R.G. Hoffmann D.L. Maas G.R. Krakower G.E. Sonnenberg A.H. Kissebah Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in african-american women Diabetes 45 1996 1635-1637
188. M. Rosenbaum M. Nicolson J. Hirsch S.B. Heymsfield D. Gallagher F. Chu R.L. Leibel Effects of gender, body composition, and menopause on plasma concentrations of leptin J. Clin. Endocrinol. Metab. 81 1996 3424-3427
189. M. Maamra M. Bidlingmaier M.C. Postel-Vinay Z. Wu C.J. Strasburger R.J. Ross Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors Endocrinology 142 2001 4389-4393
190. J. Kratzsch A. Lammert A. Bottner B. Seidel G. Mueller J. Thiery J. Hebebrand W. Kiess Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence J. Clin. Endocrinol. Metab. 87 2002 4587-4594
191. K.L. Clayton J.M. Holly L.M. Carlsson J. Jones T.D. Cheetham A.M. Taylor D.B. Dunger Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus Clin. Endocrinol. Oxf. 41 1994 517-524
192. M. Kelijman L.A. Frohman Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion J. Clin. Endocrinol. Metab. 71 1990 157-163
193. J.U. Weaver K. Noonan P.G. Kopelman An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity Clin. Endocrinol. Oxf. 35 1991 97-102
194. A. Weltman J.Y. Weltman M.L. Hartman R.D. Abbott A.D. Rogol W.S. Evans J.D. Veldhuis Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: Effects of gender J. Clin. Endocrinol. Metab. 78 1994 543-548
195. M.H. Rasmussen A. Hvidberg A. Juul K.M. Main A. Gotfredsen N.E. Skakkebae J. Hilsted Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects J. Clin. Endocrinol. Metab. 80 1995 1407-1415
196. N. Vahl J.O.L. Jørgensen A.G. Jurik J.S. Christiansen Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults J. Clin. Endocrinol. Metab. 81 1996 2209-2215
197. M.S. Gill A.A. Toogood P.A. O'Neill J.E. Adams M.O. Thorner S.M. Shalet P.E. Clayton Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects Clin. Endocrinol. Oxf. 47 1997 161-167
198. J.O. Johansson J. Oscarsson R. Bjarnason B.A. Bengtsson Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis Metabolism 45 1996 362-369
199. G. Massa R. Bouillon M. Vanderschueren Lodeweyckx Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty Clin. Endocrinol. Oxf. 37 1992 175-180
200. A. Caufriez F. Frankenne Y. Englert J. Golstein F. Cantraine G. Hennen G. Copinschi Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy Am. J. Physiol. 258 1990 E1014-E1019
201. V. Mirlesse F. Frankenne E. Alsat M. Poncelet G. Hennen D. Evain-Brion Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation Pediatr. Res. 34 1993 439-442
202. J. Fuglsang F.F. Lauszus S. Fisker A. Flyvbjerg P. Ovesen Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic women Growth Horm. IGF Res. 15 2005 223-230
203. H.D. McIntyre et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: Correlations with fetal growth J. Clin. Endocrinol. Metab. 85 2000 1143-1150
204. Z. Laron A. Pertzelan S. Mannheimer Genetic pituitary dwarfism with high serum concentration of growth hormone - a new inborn error of metabolism? Isr. J. Med. Sci. 2 1966 152-155
205. Z. Laron Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958-2003 J. Clin. Endocrinol. Metab. 89 2004 1031-1044
206. R. Eshet Z. Laron A. Pertzelan R. Arnon M. Dintzman Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism Isr. J. Med. Sci. 20 1984 8-11
207. G. Baumann M.A. Shaw R.J. Winter Absence of the plasma growth hormone-binding protein in Laron-type dwarfism J. Clin. Endocrinol. Metab. 65 1987 814-816
208. W.H. Daughaday B. Trivedi Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism) Proc. Natl. Acad. Sci. USA 84 1987 4636-4640
209. A.L. Rosenbloom J. GuevaraAguirre R.G. Rosenfeld P.J. Fielder The little women of Loja - growth hormone-receptor deficiency in an inbred population of southern Ecuador N. Engl. J. Med. 323 1990 1367-1374
210. G. Baumann M.A. Shaw T.J. Merimee Low levels of high-affinity growth hormone-binding protein in African pygmies N. Engl. J. Med. 320 1989 1705-1709
211. G. Baumann M.A. Shaw R.C. Brumbaugh J. Schwartz Short stature and decreased serum growth hormone-binding protein in the Mountain Ok people of Papua New Guinea J. Clin. Endocrinol. Metab. 72 1991 1346-1349
212. Z. Laron B. Klinger B. Erster A. Silbergeld Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism Acta Endocrinol. (Copenh.) 121 1989 603-608
213. G. Bona R. Paracchini M. Giordano P. Momigliano-Richiardi Genetic defects in GH synthesis and secretion Eur. J. Endocrinol. 151 Suppl. 1 2004 S3-S9
214. H. de Boer G.J. Blok E.A. van der Veen Clinical aspects of growth hormone deficiency in adults Endocr. Rev. 16 1995 63-86
215. D.M. Hoffman A.J. O'Sullivan R.C. Baxter K.K. Ho Diagnosis of growth-hormone deficiency in adults Lancet 343 1994 1064-1068
216. A.S. Bates A.J. Evans P. Jones R.N. Clayton Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion Clin. Endocrinol. Oxf. 42 1995 425-430
217. H.B. Baum B.M. Biller L. Katznelson D.S. Oppenheim D.R. Clemmons K.B. Cannistraro D.A. Schoenfeld S.A. Best A. Klibanski Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men - a clinical research center study J. Clin. Endocrinol. Metab. 81 1996 84-92
218. W.J. Smith T.J. Nam L.E. Underwood W.H. Busby A. Celnicker D.R. Clemmons Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children J. Clin. Endocrinol. Metab. 77 1993 1294-1299
219. M.C. Postel-Vinay A. Tar J.F. Hocquette J.P. Clot M. Fontoura R. Brauner R. Rappaport Human plasma growth hormone (GH)-binding proteins are regulated by GH and testosterone J. Clin. Endocrinol. Metab. 73 1991 197-202
220. R. Horikawa T. Tanaka N. Katsumata M. Satoh A. Nagashima T. Watanabe Y. Kokai A. Tanae I. Hibi Clinical significance of growth hormone-binding protein measurements in children Proc. Soc. Exp. Biol. Med. 206 1994 320-323
221. L.M. Carlsson K.M. Attie P.G. Compton R.V. Vitangcol T.J. Merimee Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study J. Clin. Endocrinol. Metab. 78 1994 1325-1330
222. N. Mauras L.M. Carlsson S. Murphy T.J. Merimee Growth hormone-binding protein levels: Studies of children with short stature Metabolism 43 1994 357-359
223. Z. Hochberg R.J. Barkey L. Even I. Peleg M.B. Youdim T. Amit The effect of human growth hormone therapy on GH binding protein in GH-deficient children Acta Endocrinol. Copenh. 125 1991 23-27
224. M. Tauber H. De Bouet Du Portal B. Sallerin Caute P. Rochiccioli R. Bastide Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children J. Clin. Endocrinol. Metab. 76 1993 1135-1139
225. R. Horikawa T. Tanaka N. Katsumata A. Tanae The regulatory effect of growth hormone on growth hormone-binding protein in human serum Endocr. J. 45 Suppl. 1998 S113-S115
226. S. Mandel E. Moreland V. Nichols C. Hanna S. Lafranchi Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment J. Clin. Endocrinol. Metab. 80 1995 190-194
227. J.D.P. Veldhuis R.M. Blizzard A.D. Rogol P.M.J. Martha J.L. Kirkland B.M. Sherman Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group J. Clin. Endocrinol. Metab. 74 1992 766-773
228. N.J. Hopwood et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy J. Pediatr. 123 1993 215-222
229. A.D. Goddard R. Covello S.M. Luoh T. Clackson K.M. Attie N. Gesundheit A.C. Rundle J.A. Wells L.M. Carlsson Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group N. Engl. J. Med. 333 1995 1093-1098
230. N. Davila J. Alcaniz L. Salto J. Estrada B. Barcelo G. Baumann Serum growth hormone-binding protein is unchanged in adult panhypopituitarism J. Clin. Endocrinol. Metab. 79 1994 1347-1350
231. A.A. Toogood J. Jones P.A. O'Neill M.O. Thorner S.M. Shalet The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease Clin. Endocrinol. (Oxf.) 48 1998 569-576
232. C.A. Roelen H.P. Koppeschaar W.R. de Vries P.M. Zelissen Y.E. Snel M.E. Doerga J.H. Thijssen R.A. Blankenstein High-affinity growth hormone binding protein, insulin-like growth factor I and insulin-like growth factor binding protein 3 in adults with growth hormone deficiency Eur. J. Endocrinol. 135 1996 82-86
233. G. Johannsson R. Bjarnason M. Bramnert L.M.S. Carlsson M. Degerblad P. Manhem T. Rosén M. Thorén B. Bengtsson The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender J. Clin. Endocrinol. Metab. 81 1996 1575-1581
234. C.A. Roelen H.P. Koppeschaar W.R. de Vries M.E. Doerga Y.E. Snel E. Bol P.M. Zelissen J.H. Thijssen M.A. Blankenstein High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome Metabolism 48 1999 314-318
235. W.R. de Vries H.P. Koppeschaar E. Bol C.A. Roelen G.H. Donker M.E. Doerga M. Osman-Dualeh Y.E. Snel Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy J. Endocrinol. Invest. 23 2000 449-456
236. S. Fisker K. Kristensen A.M. Rosenfalck S.B. Pedersen L. Ebdrup B. Richelsen J. Hilsted J.S. Christiansen J.O.L. Jørgensen Gene expression in subcutaneous fat and skeletal muscle of a truncated and the full-length growth hormone (GH) receptor before and after GH treatment in GH deficient adults J. Clin. Endocrinol. Metab. 86 2001 792-796
237. C.A. Roelen G.H. Donker J.H. Thijssen H.P. Koppeschaar M.A. Blankenstein High affinity growth hormone binding protein in plasma of patients with acromegaly and the effect of octreotide treatment Clin. Endocrinol. Oxf. 37 1992 373-378
238. S. Fisker A. Kaal M. Montini A. Pedroncelli G. Pagani H. Ørskov Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR) Eur. J. Endocrinol. 136 1997 61-66
239. A.J. O'Sullivan J.J. Kelly D.M. Hoffman J. Freund K.K. Ho Body composition and energy expenditure in acromegaly J. Clin. Endocrinol. Metab. 78 1994 381-386
240. T. Amit S. Ish Shalom B. Glaser M.B. Youdim Z. Hochberg Growth-hormone-binding protein in patients with acromegaly Horm. Res. 37 1992 205-211
241. I. Hernandez D. Soderlund M. Espinosa-de R. Ochoa A. Zarate M. Mercado Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly J. Neurosurg. 90 1999 647-650
242. P.J. Trainer et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant N. Engl. J. Med. 342 2000 1171-1177
243. A.J. van der Lely et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist Lancet 358 2001 1754-1759
244. M.O. Thorner C.J. Strasburger Z. Wu M. Straume M. Bidlingmaier S.S. Pezzoli K. Zib J.C. Scarlett W.F. Bennett Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH J. Clin. Endocrinol. Metab. 84 1999 2098-2103
245. J. Deladoey G. Gex J.M. Vuissoz C.J. Strasburger M.P. Wajnrajch P.E. Mullis Effect of different growth hormone (GH) mutants on the regulation of GH-receptor gene transcription in a human hepatoma cell line Eur. J. Endocrinol. 146 2002 573-581
246. U. Meinhardt A. Eble A. Besson C.J. Strasburger J.D. Sraer P.E. Mullis Regulation of growth-hormone-receptor gene expression by growth hormone and pegvisomant in human mesangial cells Kidney Int. 64 2003 421-430
247. J.W. van Neck N.F. Dits V. Cingel I.A. Hoppenbrouwers S.L. Drop A. Flyvbjerg Dose-response effects of a new growth hormone receptor antagonist (B2036-PEG) on circulating, hepatic and renal expression of the growth hormone/insulin-like growth factor system in adult mice J. Endocrinol. 167 2000 295-303
248. S.B. Oliveira M. Donnadieu J.L. Chaussain Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue Horm. Res. 39 1993 42-46
249. Y. Kobayashi A. Murata T. Yasuda M. Minagawa K. Wataki H. Ohnishi H. Niimi Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty Clin. Endocrinol. Oxf. 40 1994 351-355
250. J. DiMartino-Nardi R. Wu R. Varner W.L. Wong P. Saenger The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein J. Clin. Endocrinol. Metab. 78 1994 664-668
251. L. Tato G. Saggese L. Cavallo F. Antoniazzi A. Corrias A.M. Pasquino M. Cisternino Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment Horm. Res. 44 Suppl. 3 1995 49-54
252. F. Antoniazzi F. Bertoldo G. Zamboni R. Valentini S. Sirpresi L. Cavallo S. Adami L. Tato Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment Eur. J. Endocrinol. 133 1995 412-417
253. A. van Teunenbroek S.M. de Muinck Keizer Schrama T. Stijnen J.W. Mouton W.F. Blum M. Mercado G. Baumann S.L. Drop Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone Clin. Endocrinol. Oxf. 39 1993 77-84
254. J.J. Christiansen C.H. Gravholt S. Fisker B. Svenstrup P. Bennett J. Veldhuis M. Andersen J.S. Christiansen J.O. Jorgensen Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters Clin. Endocrinol. (Oxf.) 60 2004 461-469
255. M.A. Magiakou G. Mastorakos M.T. Gomez S.R. Rose G.P. Chrousos Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure J. Clin. Endocrinol. Metab. 78 1994 131-137
256. M. Maccario et al. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: Indirect evaluation of sensitivity to GH Eur. J. Endocrinol. 144 2001 251-256
257. C. Paul I. Seiliez J.P. Thissen A. Le Cam Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization Eur. J. Biochem. 267 2000 5849-5857
258. D. Carr H.G. Friesen Growth hormone and insulin binding to human liver J. Clin. Endocrinol. Metab. 42 1976 484-493
259. S.I. Ymer A.C. Herington Structural studies on membrane-bound and soluble growth-hormone-binding proteins of rabbit liver Biochem. J. 242 1987 713-720
260. Y. Baruch T. Amit P. Hertz R. Enat G. Shoshany M.B. Youdim Z. Hochberg Growth hormone-binding protein in partially hepatectomized rats Horm. Res. 40 1993 173-177
261. T. Bick T. Amit M. Mansur O. Bar-Am M.B. Youdim Z. Hochberg Regulation of cellular rabbit growth hormone (GH) receptor and GH-binding protein generation in vitro Endocrinology 137 1996 3977-3985
262. Y. Baruch T. Amit P. Hertz R. Enat M.B. Youdim Z. Hochberg Decreased serum growth hormone-binding protein in patients with liver cirrhosis J. Clin. Endocrinol. Metab. 73 1991 777-780
263. N. Hattori H. Kurahachi K. Ikekubo T. Ishihara K. Moridera M. Hino Y. Saiki H. Imura Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis Metabolism 41 1992 377-381
264. R.C. Cuneo P.E. Hickman J.D. Wallace B.T. Teh G. Ward J.D. Veldhuis M.J. Waters Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease Clin. Endocrinol. Oxf. 43 1995 265-275
265. J. Kratzsch W.F. Blum E. Schenker E. Keller Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis Exp. Clin. Endocrinol. Diabetes 103 1995 285-291
266. A.J. Donaghy P.J. Delhanty K.K. Ho R. Williams R.C. Baxter Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis J. Hepatol. 36 2002 751-758
267. T.C. Chang J.J. Lin S.C. Yu T.J. Chang Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver Hepatology 11 1990 123-126
268. P.E. Mullis R.W. Holl T. Lund A. Eble P.M. Brickell Regulation of human growth hormone-binding protein production by human growth hormone in a hepatoma cell line Mol. Cell. Endocrinol. 111 1995 181-190
269. Z. Zhang J. Cork P. Ye D. Lei P.O. Schwarzenberger W.R. Summer J.E. Shellito S. Nelson J.K. Kolls Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol J. Leukocyte Biol. 67 2000 856-862
270. X.J. Zhao et al. Acute alcohol inhibits TNF-alpha processing in human monocytes by inhibiting TNF/TNF-alpha-converting enzyme interactions in the cell membrane J. Immunol. 170 2003 2923-2931
271. C.M. Asplin A.C. Faria E.C. Carlsen V.A. Vaccaro R.E. Barr A. Iranmanesh M.M. Lee J.D. Veldhuis W.S. Evans Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus J. Clin. Endocrinol. Metab. 69 1989 239-245
272. R.K. Menon S. Arslanian B. May W.S. Cutfield M.A. Sperling Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus J. Clin. Endocrinol. Metab. 74 1992 934-938
273. R.W. Holl B. Siegler W.A. Scherbaum E. Heinze The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus J. Clin. Endocrinol. Metab. 76 1993 165-167
274. M.T. Munoz V. Barrios J. Pozo J. Argente Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications Pediatr. Res. 39 1996 992-998
275. S.A. Arslanian R.K. Menon A.P. Gierl B.V. Heil T.P.J. Foley Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type 1 diabetes Diabetes Med. 10 1993 833-838
276. A. Bereket C.H. Lang S.L. Blethen M.C. Gelato J. Fan R.A. Frost T.A. Wilson Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus J. Clin. Endocrinol. Metab. 80 1995 1312-1317
277. M. Mercado M.E. Molitch G. Baumann Low plasma growth hormone binding protein in IDDM Diabetes 41 1992 605-609
278. J. Kratzsch K. Keliner T. Zilkens H. Schmidt Gayk T. Selisko G.H. Scholz Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus Clin. Endocrinol. Oxf. 44 1996 673-678
279. J. Frystyk C. Skjaerbaek E. Vestbo S. Fisker H. Orskov Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes Diabetes Metab. Res. Rev. 15 1999 314-322
280. S.Y. Nam K.R. Kim Y.D. Song S.K. Lim H.C. Lee K.B. Huh GH-binding protein in obese men with varying glucose tolerance: Relationship to body fat distribution, insulin secretion and the GH-IGF-I axis Eur. J. Endocrinol. 140 1999 159-163
281. D.L. Russell-Jones M. Rattray V.J. Wilson R.H. Jones P.H. Sonksen C.R. Thomas Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: A functional role for the portal vascular link J. Mol. Endocrinol. 9 1992 257-263
282. H. Hanaire-Broutin B. Sallerin-Caute M.F. Poncet M. Tauber R. Bastide J.J. Chale R. Rosenfeld J.P. Tauber Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM Diabetologia 39 1996 1498-1504
283. R.C. Baxter J.M. Bryson J.R. Turtle Somatogenic receptors of rat liver: regulation by insulin Endocrinology 107 1980 1176-1181
284. R.K. Menon D.A. Stephan R.H. Rao Z. Shen Orr L.S. Downs Jr. C.T. Roberts Jr. D. LeRoith M.A. Sperling Tissue-specific regulation of the growth hormone receptor gene in streptozocin-induced diabetes in the rat J. Endocrinol. 142 1994 453-462
285. N.Y. Chen W.Y. Chen J.J. Kopchick Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice Endocrinology 138 1997 1988-1994
286. K.E. Bornfeldt H.J. Arnqvist B. Enberg L.S. Mathews G. Norstedt Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues J. Endocrinol. 122 1989 651-656
287. S. Ji R. Guan S.J. Frank J.L. Messina Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway J. Biol. Chem. 274 1999 13434-13442
288. K. Leung I.A. Rajkovic E. Peters I. Markus J.J. Van Wyk K.K. Ho Insulin-like growth factor I and insulin downregulate growth hormone (GH) receptors in rat osteoblasts: Evidence for a peripheral feedback loop regulating GH action Endocrinology 137 1996 2694-2702
289. K.C. Leung M.J. Waters I. Markus W.R. Baumbach K.K. Ho Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation Proc. Natl. Acad. Sci. USA 94 1997 11381-11386
290. K.C. Leung N. Doyle M. Ballesteros M.J. Waters K.K. Ho Insulin regulation of human hepatic growth hormone receptors: Divergent effects on biosynthesis and surface translocation J. Clin. Endocrinol. Metab. 85 2000 4712-4720
291. G. Baumann Growth hormone binding protein and free growth hormone in chronic renal failure Pediatr. Nephrol. 10 1996 328-330
292. J. Frystyk P. Ivarsen C. Skjaerbaek A. Flyvbjerg E.B. Pedersen H. Orskov Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure Kidney Int. 56 1999 2076-2084
293. F. Schaefer Y. Chen T. Tsao P. Nouri R. Rabkin Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia J. Clin. Invest. 108 2001 467-475
294. M.C. Postel Vinay A. Tar H. Crosnier M. Broyer R. Rappaport B. Tonshoff O. Mehls Plasma growth hormone-binding activity is low in uraemic children Pediatr. Nephrol. 5 1991 545-547
295. H.G. Maheshwari I. Rifkin J. Butler M. Norman Growth hormone binding protein in patients with renal failure Acta Endocrinol. Copenh. 127 1992 485-488
296. F. Schaefer G. Baumann D. Haffner L.M. Faunt M.L. Johnson M. Mercado E. Ritz O. Mehls J.D. Veldhuis Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: Regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma J. Clin. Endocrinol. Metab. 81 1996 22-31
297. B. Tonshoff M.J. Cronin M. Reichert D. Haffner A.M. Wingen W.F. Blum O. Mehls Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: Correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure J. Clin. Endocrinol. Metab. 82 1997 1007-1013
298. A. Kagan Z. Zadik A. Gertler M. Ulman Y. Bar Khayim Serum concentrations and peritoneal loss of growth hormone and growth-hormone-binding protein
299. T. Amit P. Hertz S. Ish Shalom R. Lotan R. Luboshitzki M.B. Youdim Z. Hochberg Effects of hypo or hyper-thyroidism on growth hormone-binding protein Clin. Endocrinol. Oxf. 35 1991 159-162
300. J.P. Miell A.M. Taylor M. Zini H.G. Maheshwari R.J. Ross R. Valcavi Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins J. Clin. Endocrinol. Metab. 76 1993 950-955
301. Z. Hochberg T. Bick Z. Harel Alterations of human growth hormone binding by rat liver membranes during hypo- and hyperthyroidism Endocrinology 126 1990 325-329
302. P.E. Mullis A. Eblé U. Marti U. Bürgi M.C. Postel-Vinay Regulation of human growth hormone receptor gene transcription by triiodothyronine (T3) Mol. Cell. Endocrinol. 147 1999 17-25
303. G.R. Ambler B.H. Breier A. Surus H.T. Blair S.N. McCutcheon A. Silbergeld P.D. Gluckman The interrelationship between and the regulation of hepatic growth hormone receptors and circulating GH binding protein in the pig Acta Endocrinol. Copenh. 126 1992 155-161
304. J.M. Brameld J.L. Atkinson J.C. Saunders J.M. Pell P.J. Buttery R.S. Gilmour Effects of growth hormone administration and dietary protein intake on insulin-like growth factor I and growth hormone receptor mRNA Expression in porcine liver, skeletal muscle, and adipose tissue J. Anim. Sci. 74 1996 1832-1841
305. S. Combes I. Louveau M. Bonneau Effect of GH administration on GH and IGF-I receptors in porcine skeletal muscle and liver in relation to plasma GH-binding protein J. Endocrinol. 155 1997 19-26
306. S. Combes I. Louveau M. Bonneau Moderate food restriction affects skeletal muscle and liver growth hormone receptors differently in pigs J. Nutr. 127 1997 1944-1949
307. J.F. Martini S.M. Villares M. Nagano M.C. Delehaye-Zervas B. Eymard P.A. Kelly M.C. Postel-Vinay Quantitative analysis by polymerase chain reaction of growth hormone receptor gene expression in human liver and muscle Endocrinology 136 1995 1355-1360
308. Y. Shuto T. Nakano N. Sanno H. Domoto H. Sugihara I. Wakabayashi Reduced growth hormone receptor messenger ribonucleic acid in an aged man with chronic malnutrition and growth hormone resistance J. Clin. Endocrinol. Metab. 84 1999 2320-2323
309. S. Fisker B. Hansen J. Fuglsang K. Kristensen P. Ovesen H. Orskov J.O. Jorgensen Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: Relationship to GH-binding protein Eur. J. Endocrinol. 150 2004 773-777
310. M. Hermansson R.B. Wickelgren F. Hammarqvist R. Bjarnason I. Wennstrom J. Wernerman B. Carlsson L.M. Carlsson Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery J. Clin. Endocrinol. Metab. 82 1997 421-428
311. R. Bjarnason R. Wickelgren M. Hermansson F. Hammarqvist B. Carlsson L.M. Carlsson Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery J. Clin. Endocrinol. Metab. 83 1998 1566-1572
312. J.E. Rowland N.J. Marshall K.C. Leung K.K. Ho A.M. Cotterill S.W. Rowlinson M.J. Waters A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays Clin. Endocrinol. (Oxf.) 56 2002 475-485
313. P. Van Kerkhof M. Smeets G.J. Strous The ubiquitin-proteasome pathway regulates the availability of the GH receptor Endocrinology 143 2002 1243-1252
314. N.E. Tawa Jr. R. Odessey A.L. Goldberg Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles J. Clin. Invest. 100 1997 197-203
315. A. Edens F. Talamantes Alternative processing of growth hormone receptor transcripts Endocr. Rev. 19 1998 559-582
316. R. Barnard P. Quirk M.J. Waters Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies J. Endocrinol. 123 1989 327-332